In addition, given consideration that FAP is also overexpressed on cancer-associated fibroblast, the MPDA also manifests a photothermal property, so replacing the loading drug with an anticancer drug may also develop a new tumor target nanodrug, which may perform well in cancer therapy combined with chemotherapy and photothermal therapy. This evidence concerns the gene FAP and neoplasm.